SAG and cancer: Therefore, the A248T mutant can serve as a model system to understand properties of arrestin constructs that can be activated independent of receptor phosphorylation and hence help development of strategies to combat with constitutively active forms of arrestin that might be involved in crucial diseases like cancer.